498 related articles for article (PubMed ID: 33904632)
1. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
2. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
3. MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.
Frigola G; Bühler M; Marginet M; Enjuanes A; Nadeu F; Papaleo N; Salido M; Haralambieva E; Alamo J; Garcia-Bragado F; Álvarez R; Ramos R; Aldecoa I; Campo E; Colomo L; Balagué O
Arch Pathol Lab Med; 2023 Aug; 147(8):896-906. PubMed ID: 36355424
[TBL] [Abstract][Full Text] [Related]
4. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
[TBL] [Abstract][Full Text] [Related]
5. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
6. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
7. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
Shao H; Xi L; Raffeld M; Feldman AL; Ketterling RP; Knudson R; Rodriguez-Canales J; Hanson J; Pittaluga S; Jaffe ES
Mod Pathol; 2011 Nov; 24(11):1421-32. PubMed ID: 21666687
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
9. Histiocytic and Dendritic Cell Neoplasms.
Pan Z; Xu ML
Surg Pathol Clin; 2019 Sep; 12(3):805-829. PubMed ID: 31352989
[TBL] [Abstract][Full Text] [Related]
10. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
[TBL] [Abstract][Full Text] [Related]
11. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
[TBL] [Abstract][Full Text] [Related]
13. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
Facchetti F; Pileri SA; Lorenzi L; Tabanelli V; Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):467-489. PubMed ID: 28695297
[TBL] [Abstract][Full Text] [Related]
14. Histiocytic and follicular dendritic cell sarcoma: Diagnostically challenging rare entities.
Patra S; Trivedi P; Kaur K
Indian J Pathol Microbiol; 2021; 64(2):316-322. PubMed ID: 33851626
[TBL] [Abstract][Full Text] [Related]
15. Follicular dendritic cell sarcoma.
Facchetti F; Simbeni M; Lorenzi L
Pathologica; 2021 Oct; 113(5):316-329. PubMed ID: 34837090
[TBL] [Abstract][Full Text] [Related]
16. Interdigitating and follicular dendritic cell sarcomas: a SEER analysis.
Perkins SM; Shinohara ET
Am J Clin Oncol; 2013 Aug; 36(4):395-8. PubMed ID: 22772431
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.
Dalia S; Jaglal M; Chervenick P; Cualing H; Sokol L
Cancers (Basel); 2014 Nov; 6(4):2275-95. PubMed ID: 25405526
[TBL] [Abstract][Full Text] [Related]
18. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell neoplasms: an overview.
Kairouz S; Hashash J; Kabbara W; McHayleh W; Tabbara IA
Am J Hematol; 2007 Oct; 82(10):924-8. PubMed ID: 17636477
[TBL] [Abstract][Full Text] [Related]
20. B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop.
Xiao W; Amador C; Cook JR; Czader M; Dave S; Dogan A; Duffield A; Goodlad J; Nejati R; Ott G; Wasik M
Am J Clin Pathol; 2023 Jun; 159(6):522-537. PubMed ID: 37040587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]